The aetiology of rheumatoid arthritis (RA) remains unknown. The involvement of the gut in reactive arthritis (ReA) and of the genitourinary system in Reiter's syndrome (RS), though recognised, is poorly understood. Distribution of phlogistic products via Batson's plexus has been suggested to account for the distribution of involved joints in these conditions.' Ankylosing spondylitis (AS) too has been associated with gut bacteria, including Klebsiella pneumoniae.2 It is possible that sulphasalazine, for which efficacy has been claimed in all these conditions,46 may mediate its effects by immunosuppression of the gut associated lymphoid tissue (GALT). This is because only at concentrations above those found in the blood stream is it immunosuppressive in vitro.7 If this also applies in vivo it opens up a whole new vista of possibilities regarding the aetiopathogenesis of these disorders.
The gut is a lymphoid organ at the heart of the secretory immune system, which is known to be involved in immune 34 If we include the synovial membrane as part of the secretory immune system then the pattern of involvement of seemingly unrelated tissues within this system falls into place. It is difficult otherwise to imagine how an antigen itself would specifically seek out these sites, but easier to construe that some primary fault in the migratory behaviour of lymphocytes operating within the secretory immune system could result in pathological sequelae at various points within the system. Such an abnormality may be viewed as an 'iteropathy' (iter-journey). Further studies into extrinsic and genetic factors affecting the itinerant proclivities of gut related lymphocytes may yield useful information regarding the aetiopathogenesis of rheumatoid arthritis and Sjogren's syndrome as well as the seronegative arthritides.
Dumonde has stated 'It is our view that lymphocyte activation products such as the lymphokine factors regulate the balance between inflammatory surveillance and adjuvant function of the cellular immune response by acting on cell co-operation or by controlling the traffic of lymphoid cell populations through critical regions of lymphoid and vascular tissue'. 35 The above arguments are in agreement with these remarks, except that the role attributed by Dumonde to lymphokines may in iteropathies be ascribed to exogenous agents. The iteropathy concept is intended to provoke thought about intestinal lymphocyte itineraries and the circumstances that may disturb them. These may include diet. As an example, vitamin A deficiency or protein-calorie malnutrition in rats have been shown to impair Rhelumatoid arthritis and gut related Iymphocytes 699 localisation of mesenteric lymphoblasts following adoptive transfer.36 Another candidate would be gut infection as seen in ReA. In either case the pathological process would be deemed to commence as a result of an iteropathy, the subsequent pathological events being dependent upon the initiating cause. In one scenario the antigen would gain entry to the joint as a passenger bound to a lymphocyte that it had rendered iteropathic, e.g., chlamrndia (J Dixey et al, unpublished data) or parvovirus.:7 In another scenario the iteropathy could be induced within the GALT by an extrinsic antigen, e.g., bacterial cell wall, and the subsequent events within the joints could possibly be the result of cross reactivity.
Yet another version that has a certain appeal concerns the interaction of microbial products and HLA antigens. In AS the HLA-B27 antigen has been shown to possess receptor properties for the 'modifying factor' released by certain plasmid infected enteric bacteria.38 Might this modifying factor also modify the subsequent itinerant properties of HLA-B27+ GALT cells? If this were so it would raise similar questions for other arthropathies once the principle was established.
All these scenarios assume the lymphocyte itself to be iteropathic. An alternative possibility is that the iteropathy is the result of qualitative changes in high endothelial venules induced by these antigens. In this context it is of interest to note that several agents, including bacterial lipopolysaccharide, stimulate lymphocyte-endothelial cell adhesion in tissue culture. 9 This, however, leaves unexplained how they reach the high endothelial venules and why they should affect such seemingly unrelated sites. Thus when the routes taken physiologically by GALT are known it requires less imagination to conclude that these lymphocytes should be the target of disease causing agents, rather than the end organs (i.e., the joints) characteristic of the ensuing disease.
Whatever the mechanism(s), the subject of lymphocyte traffic is at last receiving increasing attention.4t 4' It is to be hoped that if this should indeed prove to be the fundamental link between gut and joint pathology in these diseases more effective treatment will be forthcoming, particularly for RA. This will require us to focus our therapeutic endeavours on the iteropathy rather than the consequences of chronic inflammation. 
